Bracing for Impact: The Future of Hub, PAP, and Affordability Programs Under the Inflation Reduction Act

In his more than 25-year career, Chris has become a recognized voice in the patient affordability and specialty medication arena, pioneering prominent copay and patient affordability programs, and creating innovative solutions for his clients.

Sarah Butler is a healthcare executive with experience leading sales, marketing, operations, advisory services, and product solutions. Prior to ADVI, she founded Rimrock Health LLC, where she advised companies focused on improving the US Healthcare system including a patient coop that seeks to amplify the patient voice to the life sciences industry, a tech-enabled adherence company on its growth strategy, and a pharmacy business focused on digital expansion.

Sarah is on the Board of HealthWomen, a non-profit focused on delivering evidence-based resources for women. She was previously a founding Board member for ShareBaby, a non-profit focused on giving women and children the best start possible in the Baltimore metro area.

Sarah has an MHS in Health Policy from the Johns Hopkins University Bloomberg School of Public Health and a BA in History from the University of Richmond.

Richard has over 20 years’ experience in healthcare marketing. He holds the title of Director, Oncology Patients Solutions & Alliances where he leads the marketing efforts for Pfizer’s US Oncology portfolio of patient services, including their signature program, Pfizer Oncology Together.

Prior to joining Pfizer in 2012, he held customer strategy and analytics roles at various agencies for IPG, Omnicom and Publicis. Richard has successfully launched a myriad of copay, access and reimbursement programs for primary and specialty care.

Don is currently the Sr. VP of Market Access at Stemline Therapeutics, a Menarini Group Company. 

Previously Don has served as the Sr. VP of Market Access at Acceleron Pharma; Sr. VP of Market Access at AstraZeneca; Vice President Market Access at Celgene; and Sr. VP of Access and Head of Established Products At Bayer.   

Don was the third commercial hire and Vice President of Access for Ironwood Pharmaceuticals from 2011-2014.

Don spent much of his career at AstraZeneca where he held several roles of increasing
responsibility including Senior Counsel, Senior Director Contract Strategy, Area Sales Director, Vice President Managed Markets and Commercial Brand Leader for Crestor.

Don is a Graduate of the Widener University School of Law and The University of Delaware.